InvestSMART

BBX Minerals Limited (ASX: BBX) - Announcements

Current share price for BBX : $0.024 0.003 (14.29%)+

ASX company news and announcements for BBX Minerals Limited (BBX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BBX Minerals Limited (BBX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BBX Minerals Limited (BBX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BBX Minerals Limited (BBX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Commencement of follow up testing and optimisation 8 May 2023 9:31AM $0.070 $0.024 fallen by 65.71%
$18 Beginning of Environmental Study for Tres Estados Project 4 May 2023 11:09AM $0.068 $0.024 fallen by 64.71%
$18 Quarterly Activities/Appendix 5B Cash Flow Report 28 Apr 2023 11:11AM $0.078 $0.024 fallen by 69.23%
$18 Details of Company Address 18 Apr 2023 4:28PM $0.084 $0.024 fallen by 71.43%
$18 Notice under section 708A(5)(e) of the Corporations Act 6 Apr 2023 6:58PM $0.089 $0.024 fallen by 73.03%
$18 Application for quotation of securities - BBX 6 Apr 2023 6:48PM $0.089 $0.024 fallen by 73.03%
$18 Proposed issue of securities - BBX 31 Mar 2023 8:15AM $0.100 $0.024 fallen by 76%
$18 BBX Secures Investment of $3 Million 31 Mar 2023 8:14AM $0.100 $0.024 fallen by 76%
$18 Half Year Interim Financial Report 16 Mar 2023 4:49PM $0.120 $0.024 fallen by 80%
$18 Corporate Presentation - PDAC 6 Mar 2023 1:05PM $0.105 $0.024 fallen by 77.14%
$18 Bioleaching - Next Steps 6 Mar 2023 9:41AM $0.105 $0.024 fallen by 77.14%
$18 Excellent results from initial pilot plant testing 27 Feb 2023 10:01AM $0.150 $0.024 fallen by 84%
$18 Initial Director's Interest Notice 9 Feb 2023 6:40PM $0.140 $0.024 fallen by 82.86%
$18 Key Board Appointment to Advance Development Strategy 6 Feb 2023 10:26AM $0.145 $0.024 fallen by 83.45%
$18 Quarterly Activities/Appendix 5B Cash Flow Report 30 Jan 2023 12:41PM $0.130 $0.024 fallen by 81.54%
$18 Updated MRE at Tres Estados - 725,230 5E PGM Ounces 25 Jan 2023 9:49AM $0.120 $0.024 fallen by 80%
$18 Convertible Loan Facility Extended 11 Jan 2023 4:12PM $0.105 $0.024 fallen by 77.14%
$18 Change in substantial holding 9 Jan 2023 4:46PM $0.099 $0.024 fallen by 75.76%
$18 Change of Director's Interest Notice - AD 4 Jan 2023 8:21AM $0.094 $0.024 fallen by 74.47%
$18 Notice under section 708A(5)(e) of the Corporations Act 29 Dec 2022 1:50PM $0.100 $0.024 fallen by 76%
$18 Application for quotation of securities - BBX 29 Dec 2022 1:31PM $0.090 $0.024 fallen by 73.33%
$18 Change of Director's Interest Notice - KP 28 Dec 2022 12:13PM $0.090 $0.024 fallen by 73.33%
$18 Bioleaching test work continues to show excellent results 19 Dec 2022 9:22AM $0.073 $0.024 fallen by 67.12%
$18 Assay Results - EMD-004 to 012 16 Dec 2022 4:26PM $0.073 $0.024 fallen by 67.12%
$18 Change of Director's Interest Notice X3 5 Dec 2022 4:45PM $0.072 $0.024 fallen by 66.67%

76 - 100 of 688 results

Page 4 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.